MedPath

Role of Vitamin B12 levels in evaluating the disease outcome among patients with sepsis

Not Applicable
Conditions
Health Condition 1: A419- Sepsis, unspecified organism
Registration Number
CTRI/2023/10/058838
Lead Sponsor
Indian Council of Medical Research (ICMR) - Short Term Studentship (STS)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Newly diagnosed patients with sepsis (according to Sepsis-3 criteria) >18 years, admitted in

the medical ICU

2. Those providing informed consent to participate in the study

Exclusion Criteria

1. Pregnant females

2. Diagnosed patients of cancers, hepatic dysfunction, severe malnutrition, immunodeficiency

disorders

3. Known patients having hematological diseases

4. Patients on steroid therapy

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Association the between Serum Vitamin B12 levels and 28-day mortality in patients having <br/ ><br>sepsis <br/ ><br>Timepoint: 4 weeks
Secondary Outcome Measures
NameTimeMethod
Association between serum folic acid levels & albumin-to-fibrinogen ratio, & 28-day <br/ ><br>mortality in patients with sepsis compared to other sepsis markers.Timepoint: 4 weeks
© Copyright 2025. All Rights Reserved by MedPath